c-FLIP and microRNA 708-5p gene expression in newly diagnosed and chemotherapy in acute myeloid leukemia of Iraqi patient

BACKGROUND: C-FLICE-like inhibitory protein (c-FLIP) is a protein that does not merely block apoptosis signaling but also adjusts further pathways of cell death. Acute myeloid leukemia (AML), a nonhomogeneous hematologic malignancy, is the highly common form of AML among adults and is described thro...

Full description

Saved in:
Bibliographic Details
Main Authors: Jaafar Sadiq Jaafar, Hiba Muneer Abdual Hassan Al-Kafagi, Israa Hussein Hamzah
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Iraqi Journal of Hematology
Subjects:
Online Access:https://journals.lww.com/10.4103/ijh.ijh_48_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850147387753889792
author Jaafar Sadiq Jaafar
Hiba Muneer Abdual Hassan Al-Kafagi
Israa Hussein Hamzah
author_facet Jaafar Sadiq Jaafar
Hiba Muneer Abdual Hassan Al-Kafagi
Israa Hussein Hamzah
author_sort Jaafar Sadiq Jaafar
collection DOAJ
description BACKGROUND: C-FLICE-like inhibitory protein (c-FLIP) is a protein that does not merely block apoptosis signaling but also adjusts further pathways of cell death. Acute myeloid leukemia (AML), a nonhomogeneous hematologic malignancy, is the highly common form of AML among adults and is described through the clonal enlargement of myeloid blasts in the bone marrow (BM), peripheral blood, and/or else tissues. OBJECTIVES: The aims of this study were to investigate the role of c-FLIP and microRNA (miRNA) 708-5p as a prospective prognostic biomarker as well as the therapeutic goal in AML. PATIENTS MATERIALS AND METHODS: This study includes two groups of patients (40) individuals newly diagnosed AML patients, (20) AML taking chemotherapy, and (50) apparently healthy volunteers. The study was conducted at the National Center of Hematology/Mustansiriyah University. The methods employed in the analysis include total RNA extraction, complementary cDNA synthesis, and quantitative real-time polymerase chain reaction (PCR) were used to evaluate the gene expression of cFLIP and miRNA-708-5p. Complete blood count to estimate some hematological parameters. RESULTS: The expression of c-FLIP was notably higher in both newly diagnosed and patients under chemotherapy compared to controls with fold expression (3.291 and 2.92), respectively, with a highly significant (P = 0.0001). The increase in miRNA 708-5p expression in newly diagnosed patients with fold expression (5.345), whereas downregulation in patients under chemotherapy with fold expression (0.789) indicates that treatment may restore its levels, contributing to the suppression of c-FLIP and promoting apoptosis. CONCLUSION: The c-FLIP and miRNA708-5p gene might be used as a biological marker for the AML initial diagnosis. The researches emphasize the role of miRNA 708-5p as a tumor suppressor, which negatively regulates the antiapoptotic protein c-FLIP, indicating its potential as a therapeutic target in AML treatment. By modulating the levels of miRNA708-5p, it may be possible to regulate the expression of c-FLIP, thus enhancing the effectiveness of apoptosis-inducing therapies. This suggests the promising development of miRNA-based therapies as part of AML treatment strategies. Furthermore, miRNA 708-5p can act as a prognostic indicator in AML, with its expression levels offering valuable insights into disease progression and patient response to treatment. Further research into miRNA 708-5p can lead to a better understanding of its role in AML pathogenesis and its potential applications in clinical practice.
format Article
id doaj-art-089017ed1d4d49ff9e2b94455a401d9c
institution OA Journals
issn 2072-8069
2543-2702
language English
publishDate 2024-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Iraqi Journal of Hematology
spelling doaj-art-089017ed1d4d49ff9e2b94455a401d9c2025-08-20T02:27:34ZengWolters Kluwer Medknow PublicationsIraqi Journal of Hematology2072-80692543-27022024-12-0113226226810.4103/ijh.ijh_48_24c-FLIP and microRNA 708-5p gene expression in newly diagnosed and chemotherapy in acute myeloid leukemia of Iraqi patientJaafar Sadiq JaafarHiba Muneer Abdual Hassan Al-KafagiIsraa Hussein HamzahBACKGROUND: C-FLICE-like inhibitory protein (c-FLIP) is a protein that does not merely block apoptosis signaling but also adjusts further pathways of cell death. Acute myeloid leukemia (AML), a nonhomogeneous hematologic malignancy, is the highly common form of AML among adults and is described through the clonal enlargement of myeloid blasts in the bone marrow (BM), peripheral blood, and/or else tissues. OBJECTIVES: The aims of this study were to investigate the role of c-FLIP and microRNA (miRNA) 708-5p as a prospective prognostic biomarker as well as the therapeutic goal in AML. PATIENTS MATERIALS AND METHODS: This study includes two groups of patients (40) individuals newly diagnosed AML patients, (20) AML taking chemotherapy, and (50) apparently healthy volunteers. The study was conducted at the National Center of Hematology/Mustansiriyah University. The methods employed in the analysis include total RNA extraction, complementary cDNA synthesis, and quantitative real-time polymerase chain reaction (PCR) were used to evaluate the gene expression of cFLIP and miRNA-708-5p. Complete blood count to estimate some hematological parameters. RESULTS: The expression of c-FLIP was notably higher in both newly diagnosed and patients under chemotherapy compared to controls with fold expression (3.291 and 2.92), respectively, with a highly significant (P = 0.0001). The increase in miRNA 708-5p expression in newly diagnosed patients with fold expression (5.345), whereas downregulation in patients under chemotherapy with fold expression (0.789) indicates that treatment may restore its levels, contributing to the suppression of c-FLIP and promoting apoptosis. CONCLUSION: The c-FLIP and miRNA708-5p gene might be used as a biological marker for the AML initial diagnosis. The researches emphasize the role of miRNA 708-5p as a tumor suppressor, which negatively regulates the antiapoptotic protein c-FLIP, indicating its potential as a therapeutic target in AML treatment. By modulating the levels of miRNA708-5p, it may be possible to regulate the expression of c-FLIP, thus enhancing the effectiveness of apoptosis-inducing therapies. This suggests the promising development of miRNA-based therapies as part of AML treatment strategies. Furthermore, miRNA 708-5p can act as a prognostic indicator in AML, with its expression levels offering valuable insights into disease progression and patient response to treatment. Further research into miRNA 708-5p can lead to a better understanding of its role in AML pathogenesis and its potential applications in clinical practice.https://journals.lww.com/10.4103/ijh.ijh_48_24acute myeloid leukemiacellular-flice-like inhibitory proteingene expressionmicrorna 708-5preal-time polymerase chain reaction
spellingShingle Jaafar Sadiq Jaafar
Hiba Muneer Abdual Hassan Al-Kafagi
Israa Hussein Hamzah
c-FLIP and microRNA 708-5p gene expression in newly diagnosed and chemotherapy in acute myeloid leukemia of Iraqi patient
Iraqi Journal of Hematology
acute myeloid leukemia
cellular-flice-like inhibitory protein
gene expression
microrna 708-5p
real-time polymerase chain reaction
title c-FLIP and microRNA 708-5p gene expression in newly diagnosed and chemotherapy in acute myeloid leukemia of Iraqi patient
title_full c-FLIP and microRNA 708-5p gene expression in newly diagnosed and chemotherapy in acute myeloid leukemia of Iraqi patient
title_fullStr c-FLIP and microRNA 708-5p gene expression in newly diagnosed and chemotherapy in acute myeloid leukemia of Iraqi patient
title_full_unstemmed c-FLIP and microRNA 708-5p gene expression in newly diagnosed and chemotherapy in acute myeloid leukemia of Iraqi patient
title_short c-FLIP and microRNA 708-5p gene expression in newly diagnosed and chemotherapy in acute myeloid leukemia of Iraqi patient
title_sort c flip and microrna 708 5p gene expression in newly diagnosed and chemotherapy in acute myeloid leukemia of iraqi patient
topic acute myeloid leukemia
cellular-flice-like inhibitory protein
gene expression
microrna 708-5p
real-time polymerase chain reaction
url https://journals.lww.com/10.4103/ijh.ijh_48_24
work_keys_str_mv AT jaafarsadiqjaafar cflipandmicrorna7085pgeneexpressioninnewlydiagnosedandchemotherapyinacutemyeloidleukemiaofiraqipatient
AT hibamuneerabdualhassanalkafagi cflipandmicrorna7085pgeneexpressioninnewlydiagnosedandchemotherapyinacutemyeloidleukemiaofiraqipatient
AT israahusseinhamzah cflipandmicrorna7085pgeneexpressioninnewlydiagnosedandchemotherapyinacutemyeloidleukemiaofiraqipatient